Source: Mikrochimica acta [Mikrochim Acta] 2020 Jun 03; Vol. 187 (6), pp. 366. Date of Electronic Publication: 2020 Jun 03.Publisher: Springer-Verlag Country of Publication: Austria NLM ID: 7808782 Publication Model: Electronic Cited Medium: Internet ISSN: 1436-5073

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Development and Validation of HPLC and HPTLC Methods for Therapeutic Drug Monitoring of Capecitabine in Colorectal Cancer Patients.

Authors : Thorat SG; Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Mahatma Jyotiba Fuley Shaikshanik Parisar, Amravati Road, Nagpur-440033, Maharashtra, India.; Chikhale RV

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/blood ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacokinetics ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use

Source: Journal of chromatographic science [J Chromatogr Sci] 2020 Jan 17; Vol. 57 (10), pp. 892-900.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0173225 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies.

Authors : Trivedi ND; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.; Armstrong S

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; Capecitabine/Capecitabine/Capecitabine/*administration & dosage

Source: Cancer medicine [Cancer Med] 2021 Mar; Vol. 10 (6), pp. 1944-1954. Date of Electronic Publication: 2021 Feb 27.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients.

Authors : Lu Y; State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Stem Cell Research Center, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.; Huang Y

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Biomarkers, Pharmacological/Biomarkers, Pharmacological/Biomarkers, Pharmacological/*metabolism ; Capecitabine/Capecitabine/Capecitabine/*therapeutic use

Source: BMC immunology [BMC Immunol] 2020 Aug 08; Vol. 21 (1), pp. 46. Date of Electronic Publication: 2020 Aug 08.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer.

Authors : Shi M; Department of Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, No. 197 Ruijin Er Road, Shanghai, 200025, China.; Ma T

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage ; Capecitabine/Capecitabine/Capecitabine/*administration & dosage ; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*drug therapy

Source: Trials [Trials] 2020 Mar 06; Vol. 21 (1), pp. 249. Date of Electronic Publication: 2020 Mar 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Capecitabine lipid nanoparticles for anti-colon cancer activity in 1,2-dimethylhydrazine-induced colon cancer: preparation, cytotoxic, pharmacokinetic, and pathological evaluation.

Authors : Dudhipala N; a Department of Pharmaceutics , Vaagdevi Pharmacy College , Warangal , India.; Puchchakayala G

Subjects: 1,2-Dimethylhydrazine/1,2-Dimethylhydrazine/1,2-Dimethylhydrazine/*toxicity ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacokinetics ; Capecitabine/Capecitabine/Capecitabine/*pharmacokinetics

Source: Drug development and industrial pharmacy [Drug Dev Ind Pharm] 2018 Oct; Vol. 44 (10), pp. 1572-1582. Date of Electronic Publication: 2018 Jul 04.Publisher: Informa Healthcare Country of Publication: England NLM ID: 7802620 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer.

Authors : Peng J; Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.; Tan C

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage ; Capecitabine/Capecitabine/Capecitabine/*administration & dosage ; Oxaliplatin/Oxaliplatin/Oxaliplatin/*administration & dosage

Source: PloS one [PLoS One] 2018 Jun 28; Vol. 13 (6), pp. e0199553. Date of Electronic Publication: 2018 Jun 28 (Print Publication: 2018).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Capecitabine-loaded anti-cancer nanocomposite hydrogel drug delivery systems: in vitro and in vivo efficacy against the 4T1 murine breast cancer cells.

Authors : Taleblou N; Faculty of Chemical Engineering, Urmia University of Technology, Urmia, Iran.; Sirousazar M

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*chemistry ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*pathology

Source: Journal of biomaterials science. Polymer edition [J Biomater Sci Polym Ed] 2020 Jan; Vol. 31 (1), pp. 72-92. Date of Electronic Publication: 2019 Oct 11.Publisher: Taylor and Francis Country of Publication: England NLM ID: 9007393 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Capecitabine-loaded nanoniosomes and evaluation of anticancer efficacy.

Authors : Nazari-Vanani R; a Nanomedicine and Nanobiology Research Center , Shiraz University of Medical Sciences , Shiraz , Iran.; Karimian K

Source: Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2019 Dec; Vol. 47 (1), pp. 420-426.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101594777 Publication Model: Print Cited Medium: Internet ISSN: 2169-141X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer.

Authors : Chionh F; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia.; Gebski V

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Carcinoma/Carcinoma/Carcinoma/*drug therapy ; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*drug therapy

Source: Scientific reports [Sci Rep] 2022 Jan 24; Vol. 12 (1), pp. 1238. Date of Electronic Publication: 2022 Jan 24.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Ultrasound-assisted dispersive solid-phase microextraction of capecitabine by multi-stimuli responsive molecularly imprinted polymer modified with chitosan nanoparticles followed by HPLC analysis.

Development and Validation of HPLC and HPTLC Methods for Therapeutic Drug Monitoring of Capecitabine in Colorectal Cancer Patients.

A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies.

CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients.

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer.

Capecitabine lipid nanoparticles for anti-colon cancer activity in 1,2-dimethylhydrazine-induced colon cancer: preparation, cytotoxic, pharmacokinetic, and pathological evaluation.

Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer.

Capecitabine-loaded anti-cancer nanocomposite hydrogel drug delivery systems: in vitro and in vivo efficacy against the 4T1 murine breast cancer cells.

Capecitabine-loaded nanoniosomes and evaluation of anticancer efficacy.

VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer.

اتصل بنا

اتبع